Table 3. Percentage 5-year survival by time period, diagnostic group and agea.
| 1981–1987 | 1988–1994 | 1995–2000 | ||
|---|---|---|---|---|
| Diagnostic group | Gender | Rate (95% CI) | Rate (95% CI) | Rate (95% CI) |
| All types | All persons | 51.13 (42.63, 59.62) | 61.74 (52.86, 70.62) | 62.37 (52.52, 72.21) |
| Male | 57.14 (44.18, 70.10) | 59.70 (47.96, 71.45) | 61.90 (47.22, 76.59) | |
| Female | 46.75 (35.61, 57.90) | 64.58 (51.05, 78.11) | 62.75 (49.48, 76.01) | |
| Osteosarcoma | All persons | 60.61 (48.82, 72.39) | 58.46 (46.48, 70.44) | 57.14 (44.18, 70.10) |
| Male | 68.97 (52.13, 85.80) | 58.06 (40.69, 75.44) | 54.17 (34.23, 74.10) | |
| Female | 54.05 (38.00, 70.11) | 58.82 (42.28, 75.37) | 59.38 (42.36, 76.39) | |
| Chondrosarcoma | All persons | 42.86 (9.90, 81.59) | 50.00 (1.26, 98.74) | 67.00 (22.28, 95.67) |
| Male | 66.67 (9.43, 99.16) | 50.00 (1.26, 98.74) | 75.00 (19.41, 99.16) | |
| Female | 25.00 (0.63, 80.59) | 0.00 (—) | 50.00 (1.26, 98.74) | |
| Ewing sarcoma | All persons | 37.50 (24.82, 50.18) | 65.96 (52.41, 79.50) | 70.00 (53.60, 86.40) |
| Male | 36.36 (16.26, 56.47) | 60.61 (43.93, 77.28) | 71.43 (47.76, 95.09) | |
| Female | 38.24 (21.90, 54.57) | 78.57 (49.20, 95.34) | 68.75 (46.04, 91.46) | |
| Otherb | All persons | 100.00 (39.76, 100.00) | 100.00 (2.50, 100.00) | 100.00 (2.50, 100.00) |
| Male | 100.00 (15.81, 100.00) | 100.00 (2.50, 100.00) | 0.00 (—) | |
| Female | 100.00 (15.81, 100.00) | 0.00 (—) | 100.00 (2.50, 100.00) |
CI=confidence interval.
a
Rates data include 95% CI in parentheses.
b
Other specified and unspecified tumours.